Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology-Reference-Cited by-同舟云学术

Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology

Published:2013-03-15 Issue:3 Volume:8 Page:e58938
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

McKinley Eliot T.,Ayers Gregory D.,Smith R. Adam,Saleh Samir A.,Zhao Ping,Washington Mary Kay,Coffey Robert J.,Manning H. Charles

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Carbon-11-thymidine and FDG to measure therapy response;AF Shields;J Nucl Med,1998

2. Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging;AF Shields;J Nucl Med,1996

3. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine;MJ Reinhardt;J Nucl Med,1997

4. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography;H Barthel;Cancer Res,2003

5. Imaging proliferation in brain tumors with F-18-FLT PET: Comparison with F-18-FDG;W Chen;Journal of Nuclear Medicine,2005

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Medicine Imaging Techniques in Glioblastomas;Neurochemical Research;2024-09-05

2. Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging;Clinical Cancer Research;2024-03-17

3. Exploring the applicability of a lesion segmentation method on [18F]fluorothymidine PET/CT images in diffuse large B-cell lymphoma;European Journal of Hybrid Imaging;2023-12-25

4. Verification of Therapeutic Effect through Accelerator Mass Spectrometry‐Based Single Cell Level Quantification of hESC‐Endothelial Cells Distributed into an Ischemic Model;Advanced Healthcare Materials;2023-05

5. PET Imaging in Clinical Oncology;Handbook of Cancer and Immunology;2023